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ABSTRACT
The ability of Ns, 02'-dibutyryl cyclic AMP (DBcAMP) to regulate a number of metabolic
events in four lines of cultured rat hepatomas has been examined. Although dexamethasone
induces tyrosine transaminase in all four lines, DBcAMP induces this enzyme normally
only in H35 cells. A slight increase in transaminase activity was seen with MHICI cells and
HTC cells, but no effect was detectable in RLC cells . In contrast, phosphoenolpyruvate
carboxykinase activity is increased by both agents in H35 and MH1C1 cells, but neither
had any effect in HTC or RLC cells .
DBcAMP caused a rapid inhibition of the growth rate and DNA synthesis and an in-
crease in protein content in both H35 and MH,C, cells but not in HTC or RLC cells . The
effect of DBcAMP on DNA synthesis in MH,CI cells could be reversed by deoxycytidine
as is also the case with H35 cells.
The resistance of HTC and RLC cells to DBcAMP was not due to reduced uptake or
deacylation as judged by studies with [3H]DBcAMP. The cyclic nucleotide appears to enter
the cells by passive diffusion as the intracellular concentration approaches that in the
medium within 30-60 min. Possible explanations for the differential responses observed
are discussed.
INTRODUCTION
In the past few years increasing emphasis has been placed in culture and have proven to be
been placed on the use of cultured cells in studies especially useful in studies of the mechanism of
of biochemical regulatory mechanisms in eukary- regulation of specific protein synthesis by hor-
otic systems. A limited variety of cells derived from
chemically induced rat hepatomas' (1-4) have
taneous hepatoma. Injection of these cells into rats
'Although the RLC cells were originally derived produces rapid tumor formation (5), and as a
from normal rat liver, at the time of their use in our result, we have considered them to be hepatoma
experiments, they appear to have become a spon- cells.
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181mones and cyclic AMP (CAMP) .' There does
appear to be some justification in using cultured
hepatoma cells as a model system to study the
control of normal liver function. In the more
"well-differentiated" hepatomas (1), especially
the Reuber H35 (6, 7) and MH ICI (3, 8-11), a
number of normal hepatic processes appear to
persist as well as certain features of the regulatory
circuits controlling these processes .
One of the major purposes for using cultured
cells in these studies has been to search for or to
generate variants in which some aspect of the
regulatory system under investigation is selectively
altered or deleted. Such variants could provide
an important means of dissecting out the com-
ponent parts of various regulatory processes
(e.g., induction of tyrosine transaminase (EC
4.2.1 .13) by glucocorticoids, insulin, and sAMP,
etc.), as has been so successfully exploited in
prokaryotic systems. To date, this potential has
been only modestly explored with hepatoma cells
either through extensive cloning (12), by re-
passage of the tumor cells in animals (13), or by
somatic cell hybridization (14-18) . The results,
however, do provide support for the expectation
that potentially useful regulatory variants may
be obtained by suitable manipulation of cultured
hepatoma cells.
We have approached this problem by analyzing
the effects of N6,02'-dibutyryl cyclic AMP
(DBcAMP) on a number of metabolic processes
in four hepatoma cell lines to determine whether
any of these might already be variant in their
responses. As will be described in this report, 3
certain differential responses to DBcAMP have
been observed providing support for the specific
expectation that variants with selective alterations
in the CAMP regulatory system may in fact be
obtained from existing cultured hepatoma cells .
MATERIALS AND METHODS
Cell Growth
All cell lines were grown in monolayer culture as
described previously for Reuber H35 cells (6, 7, 19,
20) except that the final concentration of calf serum
'Abbreviations used in this paper . cAMP, cyclic 3' : 5'-
AMP; DBcAMP, N6 ,02r-dibutyryl cyclic 3' :5'-
AMP; MBcAMP, N6- or 02'-monobutyryl cyclic
3' :5'-AMP; PEP, phosphoenolpyruvate .
3 A preliminary report of a portion of this work has
been made (19) .
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was 10% instead of 5% . The number of cells was
determined with the aid of a hemacytometer or,
in some cases, by measuring DNA content after har-
vesting by agitation with 1 mM EDTA (20) . For
the latter measurements the modified diphenylamine
method of Burton was used (21) . Protein was esti-
mated by the method of Lowry et al. (22).
ENZYME ASSAYS : After reaching confluency,
cells were placed in serum-free medium 16-20 h be-
fore additions. 5 h after the various additions were
made, the cells were harvested by scraping with a
rubber policeman and collected by centrifugation
(6, 7, 19, 20). Lysis was accomplished by three cycles
of freezing and thawing in 0 .15 M KCl-1 mM EDTA .
Tyrosine transaminase and phosphoenolpyruvate
(PEP) carboxykinase (EC 4.1 .1 .32) activities were
assayed in the supernatant fraction after centrifuga-
tion of the lysates at 20,000 g for 20 min as described
previously (23).
INCORPORATION OF [ 3H]DEOXYADENOSINE :
The incorporation of [ 3H]deoxyadenosine into cold
trichloracetic acid-precipitable material was measured
using the filter paper disk method of Mans and
Novelli (24) . Better than 90% of the radioactivity
in this fraction could be accounted for as DNA
nucleotides (25) . The distribution of radioactivity
incorporated from [3H]deoxyadenosine into the DNA
of the different cell lines was found to be analogous
to that found previously in H35 DNA (25).
UPTAKE AND METABOLISM OF [ 3H]DBCAMP :
[8-3H]DBcAMP was added at 0.5 mM so that the
medium contained 110,000 dpm/ml . 1 h later the
medium was removed and the cells were washed five
times rapidly with cold saline . Finally, ethanol was
added and the cells were scraped, freeze-thawed
twice, and centrifuged. Aliquots of the supernatant
fraction were counted, and the radioactivity in
N6 ,02r-dibutyryl-,N6- and 02'-monobutyryl-, and
free sAMP was determined after chromatography
of the remaining material on Whatman 1 MM paper
with a solvent system containing 1 M ammonium
acetate, pH 7.5, and ethanol (3 :7.5 vol/vol) (26).
Elution of the nucleotides was performed with water .
Analysis of the composition of monobutyryl cAMP
(MBcAMP) derivatives (i.e., N6 and 02') was per-
formed by two methods as described in the text.
COUNTING : Filters were counted in 5 ml toluene
containing 4 g/liter 2,4-diphenyloxazole and 0 .05
g/liter 1-4-bis[2-(5-phenyloxazolylphenyl)] benzene
with an efficiency of 6%, while aqueous samples
were counted in 15 ml Aquasol with an efficiency up
to 30% depending on the quantity of the sample.
Counting was performed in a Mark II liquid scintilla-
tion counter.
CHEMICALS AND RADIOISOTOPES : All tissue
culture components were purchased from Grand
Island Biological Co., Grand Island, New York or
Flow Laboratories Ltd., Scotland. [3H]Deoxyade-nosine, [3H]thymidine, and [8-3H]DBcAMP were
obtained from The Radiochemical Centre, Amer-
sham, Buckinghamshire, England. Thymidine, deoxy-
adenosine, DBcAMP, and N6-MBcAMP were sup-
pled by Boehringer Mannheim Corp., New York.
Aquasol was obtained from New England Nuclear
Corp., Boston, Mass. All other chemicals were of
analytical grade. 8-Thio cAMP analogs were kindly
provided by Dr. M. Stout of the ICN Nucleic Acid
Research Institute, Irvine, Calif. O2'-MBcAMP was
obtained from Sigma Chemical Co., St. Louis, Mo.
The purity of labeled and unlabeled DBcAMP
was 97%.
RESULTS
Enzyme Activity Changes
As illustrated in Table I, both H35 and MH 1C1
cells contain tyrosine transaminase and PEP
carboxykinase in amounts comparable to those
found in rat liver (27). Exposure of these cell
lines to dexamethasone for 5 h produces quali-
tatively similar changes in both enzymic activities
as is also the case in rat liver (27, 28) . Thus, as
with H35 cells (6), the activity of the transaminase
TABLE I
Enzyme Induction by DBcAMP and Dexamethasone in Various Hepatoma Cell Cultures
rises two- to fourfold after exposure of MH 1C1
cells to the glucocorticoid (as has also been re-
ported by Tashjian et al. with cortisol [10]) . The
carboxykinase is also elevated two- to threefold
in both cell lines (as previously reported for H35
cells [6]). (Overnight exposure of H35 and MH1C1
cells to dexamethasone produces a somewhat
greater elevation of both enzyme activities.)
In striking contrast to rat liver (27, 29) and H35
cells (6), however, DBcAMP causes only a slight
increase in the activity of the transaminase in
MH1C1 cells. At the same time, the activity of
the carboxykinase exhibits the same increase
seen in other hepatic systems (6, 27, 29) . Longer
exposure of MH1C1 cells to DBcAMP (up to 16
h), substitution of 8-methylthio-cAMP (30) or
concomitant addition of 1 mM theophylline did
not alter the observed responses.
Insulin causes a two- to threefold elevation of
tyrosine transaminase activity in MH1C1 cells but
does not influence carboxykinase activity (data
not shown). The simultaneous addition of insulin
led to a marked inhibition of the rise in PEP car-
boxykinase activity produced by dexamethasone
Cells near confluency (6-8 days except 12-14 days with MH1C1 cells) were placed in
serum-free medium 16-20 h before addition of inducers . Cells were harvested 5 h after
additions for assays as described in Materials and Methods . Each value represents the
average of the number of observations shown in parentheses with standard errors
ranging from 5 to 15%.
* The disparity in the number of observations between the two enzymes is due to the
fact that the results of one experiment in which the carboxykinase was not assayed are
included.
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Cell line Additions Concentration
Tyrosine transaminase
(u/mg protein)
PEP carboxykinase
(u/mg protein)
H35 None 36 .3 (13) 51 .4 (13)
DBcAMP 0.5 mM 107 .3 (12) 95 .6 (12)
Dexamethasone 0.2 AM 171 .4 ( 8) 94 .9 ( 8)
MH1C1 None 46 .1 (16)* 36 .6 (11)
DBcAMP 0 .5 mM 57 .8 (18)* 72 .7 (13)
Dexamethasone 0.2 AM 113.8 (10) 112 .4 (10)
HTC None 19.3 (5) 4.5 ( 5)
DBcAMP 0.5 mM 26.0 (6) 4.7 (6)
Dexamethasone 0 .1 µM 42 .7 ( 6) 4.9 ( 6)
RLC None 5 .1 ( 5) 3 .5 ( 5 )
DBcAMP 0 .5 mM 6 .2 (10) 3 .7 (10)
Dexamethasone 0 .1 AM 13 .7 ( 5) 3 .4 ( 5)and at the same time generated a synergistic in-
crease in tyrosine transaminase activity in MH1C1
cells. These results are analogous to those pre-
viously reported with H35 cells (6). DBcAMP
added together with insulin did not elevate
transaminase activity in MH1C1 cells significantly
above that seen with insulin alone . The increase
in PEP carboxykinase activity normally produced
by DBcAMP was, however, partially suppressed
by inclusion of the pancreatic hormone, as in
H35 cells (6) .
Analysis of the characteristics of PEP carboxy-
kinase in MH1C1 cells has revealed the same
nucleotide (GDP ? IDP > > > > ADP +
UDP), and divalent cation (Mn++ > Fe++
> > > > Mg++) specificity as the enzyme from
rat liver and H35 cells (6, 29).
The activity of tyrosine transaminase and
especially PEP carboxykinase is much lower in
HTC cells than in rat liver or H35 cells (Table I) .
As reported by others, however, dexamethasone
does produce a marked increase in transaminase
activity (2, 12). DBcAMP produced a marginal
increase in transaminase activity as has also been
observed by others (31), but PEP carboxykinase
activity was not altered by any of the treatments
employed.
The addition of theophylline at 1 mM alone
or in combination with DBcAMP was without
effect on either enzyme in HTC cells . Although
more prolonged incubation with dexamethasone
did produce a greater increase in transaminase
activity, prolonged exposure to DBcAMP did
not alter the response of this enzyme and neither
changed the results obtained with the carboxy-
kinase. Addition of the 8-methylthio analog of
cAMP produced a slightly greater increase in
transaminase activity than with DBcAMP (53%
vs. 35%), but PEP carboxykinase still did not
exhibit any change in activity.
In terms of both reduced basal activities and
responses to inducers, RLC cells are analogous to
HTC cells (Table I) . The effects of dexametha-
sone on tyrosine transaminase in RLC cells are
similar to those reported by others (4). Alterations
of the protocol such as those discussed above with
MH1C 1 and HTC cells also did not change the
results significantly from those shown in Table I .
EFFECTS OF DBcAMP ON CELL GROWTH
AND PROTEIN/DNA RATIO : We have pre-
viously reported that DBcAMP specifically re-
duces the rate of growth of H35 cells (20), and
the results in Table II show that MHIC, cells also
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TABLE II
Effects of DBcAMP on Growth Rate and Protein
Content in Various Hepatoma Cell Cultures
DBcAMP (0.5 mM) was first added 24 h after sub-
culture. The medium, with and without DBcAMP
was changed on days 2 and 4. On day 5 the cells
were harvested with 1 mM EDTA for determina-
tion of the cell number and the content of protein
and DNA. The doubling times were estimated
from growth curves of untreated cells constructed
from data obtained in separate experiments (20).
Each value is the average of five to six flasks with
a standard error of less than 10% .
exhibit an increase in generation time after ex-
posure to DBcAMP. In contrast, neither HTC
nor RLC cells respond to the cyclic nucleotide
even with concentrations as high as 2 mM. Ex-
posure of these cells to 8-substituted analogs of
cAMP, which are potent inhibitors of growth in
H35 and MH 1C1 cells (19, 20), also did not in-
fluence their rate of proliferation .
Fig. 1 illustrates the fact that although the
doubling time of MH1C1 cells is longer than that
of H35 cells, the time course of the effects of
DBcAMP on the growth rate of both cell lines
is similar. The effect of DBcAMP on the growth
of MH5C1 cells in this experiment was somewhat
greater than that reported in Table II. A similar
variation in the absolute degree of inhibition has
been observed in H35 cells (20).
As is also the case in H35 cells (20), the content
of protein per cell is increased in MH1C1 cells
exposed to DBcAMP, but no effect could be
detected in either HTC or RLC cells. (The con-
tent of DNA per cell was not altered by growth of
any of these cells in DBcAMP [20] .)
EFFECT OF DBcAMP ON DNA SYNTHESIS :
DBcAMP produces a marked inhibition of DNA
synthesis (as measured by [3H]deoxyadenosine
Cell line
Control
cells
DBcAMP-
treated cells
h h
Doubling time H35 30 50
MHICI 50 70
HTC 36 36
RLC 40 40
Protein/DNA H35
mg/mg
14 .7
mg/mg
19 .9
MHICI 14 .1 20 .0
HTC 12 .5 12 .6
RLC 13.6 14 .0too
800
400
290
1M
0
0
	
1 2 4 8 8
Days After Subculture
FIGURE 1 Time course of the effects of DBcAMP on
the growth of MH1C1 cells . In the case of both H35
and MH1C1 cells, approximately 1.5 X 106 cells were
placed in each flask at subculture (day 0) . DBcAMP
(0.5 mM) was first added 24 h after subculture (day 1)
and again after medium changes on days 3 and 5
with H35 cells, and day 4 with MH1C1 cells . At the
times indicated cells were frozen in situ and stored at
-30°C until assay. Cell numbers were calculated
from assays of DNA content (20) . Each value is the
average of three flasks with standard errors of less
than 10% in each case. •---~, untreated H35 cells,
81---•, DBcAMP-treated H35 cells ; A-A, untreated
MHIC1 cells; A---A, DBcAMP-treated MHICI cells.
incorporation) in both H35 (19, 25) and MH 1C1
cells as seen in Table III . No significant effect of
the cyclic nucleotide on DNA synthesis in either
HTC or RLC cells was demonstrable as with
the growth rate. Qualitatively similar results were
obtained with [3H]thymidine as the radioactive
precursor (at high specific radioactivities [19, 25]) .
REVERSAL OF DNA SYNTHESIS INHIBITION :
We have found that deoxycytidine is capable of
reversing the effects of DBcAMP on both growth
rate and DNA synthesis in H35 cells (19) . It was
TABLE III
Effect of DBcAMP on DNA Synthesis in Various
Hepatoma Cell Cultures
Cells were plated at a density of 2-4 X 105 cells
per flask and tested during the logarithmic phase of
growth (i.e., between 20-40 X 10 5 cells per flask)
which was achieved 5 days after subculture . The
medium was changed on days 3 and 5 . After the
last change of medium, DBcAMP (0.5 mM) was
added. 3 h later, 1.0 µCi of [3H]deoxyadenosine
(1 µM final concentration) was added to each flask
and 1 h later the cells were harvested for assay (25).
Each value is the average of four to five flasks with a
standard error of less than 10%.
of interest to determine whether this nucleoside
was able to prevent the inhibitory effects of
DBcAMP on DNA synthesis in MH 1C1 cells as
well. Addition of 1 mM deoxycytidine together
with DBcAMP did, in fact, essentially completely
prevent the inhibition of DNA synthesis in both
H35 and MH1C1 cells (Table IV). No effect of
DBcAMP was observed on DNA synthesis in
HTC or RLC cells in the presence or absence of
deoxycytidine.
The reversal of the effects of DBcAMP on
DNA synthesis and growth does not result simply
from inhibition of transport of the cyclic nucleo-
tide by deoxycytidine . Tyrosine transaminase is
fully inducible by DBcAMP (0 .5 mM) even in
the presence of 1 mM deoxycytidine (19) .
UPTAKE AND METABOLISM OF [3 H]DBCAMP :
The inability of HTC and RLC cells to respond
to DBcAMP could result from several factors .
The most obvious possibilities are that DBcAMP
simply does not enter these cells or is not deacyl-
ated (32). In order to study both possibilities the
uptake and metabolic fate of 0 .5 mM [3H]-
DBcAMP (labeled in the 8 position of the adenine
ring) was measured.
From the results of these studies the following
points can be made : (a) The uptake of
[3H]DBcAMP by all four cell lines reaches a
rather constant level within 30 min after its ad-
dition. (b) No association of [3H]DBcAMP (i.e.,
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[3H]Deoxyadenosine incorporation in:
Cell line
Control cells
(cpm/h/104 cells)
DBcAMP-treated cells
(cpm/h/104 cells)
H35 15 .1 8 .9
MH1CI 7 .2 4 .5
HTC 7 .7 7 .6
RLC 7 .4 7 .2TABLE IV
	
TABLE V
Reversal by Deoxycytidine of Inhibition of DNA
	
Uptake and Metabolism of [3H]DBcAMP by
Synthesis by DBcAMP in Various Hepatoma
	
Various Hepatoma Cell Cultures
Cell Cultures
Cell-associated
	
Radioactivity associated
[3H]Deoxyadenosine incorporation in :
	
radioactivity
	
per cell
(dpm/mg protein)
	
(dpm/cell X 106)
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Cells were plated at a density of 2-4 X 106 cells per
flask and tested during the logarithmic phase of
growth (i .e., between 20 and 40 X 106 cells per
flask) which was achieved 5 days after subculture .
The medium was changed on days 3 and 5 . After
the last change of medium, DBcAMP (0.5 mM)
and deoxycytidine (1 mM) were added. 3 h later,
1 .0 µCi of [3H]deoxyadenosine (1 µM final con-
centration) was added to each flask . 1 h later the
cells were harvested for assays (25) . Each value
represents the average of four to five flasks with a
standard error of less than 10% .
after washing) occurs with the culture flasks
themselves or with cells that have been previously
denatured by ethanol . (c) The washing procedure
appears to be adequate since a very low and
essentially constant amount of radioactivity is
removed by the last two washings. Thus, the
observed radioactivity most likely represents
cell-associated DBcAMP and its metabolites.
Table V compares this cell-associated radioac-
tivity after incubation of ['H]DBcAMP with each
cell line for 1 h. The amounts are expressed both
as disintegrations per minute per milligram pro-
tein and as disintegrations per minute per cell X
106. As can be seen, no significant differences in
DBcAMP uptake were observed among the H35,
HTC, and RLC cell lines, but MH1C1 cells ex-
hibited a greater degree of cell-associated radio-
activity.
In all the cell lines a significant fraction of the
DBcAMP was converted into MBcAMP (N6-
and 02'-) as judged by paper chromatography .
Radioactivity could be found not only in the
two MBcAMP derivatives but also in cAMP and,
to a lesser extent, AMP and adenosine. These
metabolites were formed in roughly equivalent
amounts in all the cell lines except for MH1C 1
cells where about 50% more radioactivity was
found in metabolites, but the proportions were
similar. Thus, after an incubation period of 1
1,000
1,620
980
890
H35, HTC, and RLC cells were grown for 4 days,
while MHIC1 cells were grown for 6 days with
regular changes of medium. After this period of
time, 110,000 dpm/ml of [3H[DBcAMP (0.5 mM)
was added and 1 h later the cells were washed
rapidly five times with ice-cold saline . Ethanol
(90%) was then added and the cells were scraped,
freeze-thawed several times, and centrifuged . The
radioactivity of the supernatant was measured and
analyzed as described in Materials and Methods .
The data are the average of three experiments,
each containing three flasks of the respective cell
lines. The standard errors ranged from 5 to 10%.
h, approximately 50% of the radioactivity in
metabolites derived from DBcAMP was found
in MBcAMP (N6- and 02'-), 10-20% in cAMP
and the rest in AMP and adenosine .
N6- and 02'-MBcAMP could not be repro-
ducibly separated by chromatography on paper
or ion-exchange thin layer plates despite the
use of a variety of solvent systems. However,
incubation of the MBcAMP fraction with 0.1
N NaOH after chromatography allowed a direct
estimate to be made of the relative amounts of
these two derivatives after rechromatography.
N6-MBcAMP is resistant to treatment with
alkali but 02'-MBcAMP is quantitatively con-
verted to cAMP which is readily separable from
N6-MBcAMP (33). Using this procedure, it was
found that roughly equal amounts of N 6- and
02'-MBcAMP were formed in all four cell lines
after incubation for 1 h with 0 .5 mM DBcAMP.
Cell line Control cells DBcAMP-treated cells
H35 2,500
H35 10 .0 9 .2 MH IC 1 3,400
MH1C1 7 .0 6 .8 HTC 1,670
HTC 4.3 4 .7 RLC 2,480
RLC 5.3 5.1
Percentage of total
cell-associated
radioactivity as
DBcAMP
Cell-associated
radioactivity as
DBcAMP
(dpin/cell X 106)
%
H35 59 590
MH1CI 39 630
HTC 60 590
RLC 56 500Another method involving ultraviolet spec-
troscopy was employed to measure the relative
amounts of Ns- and O 2'-MBcAMP, which did
not require chemical treatment or rechroma-
tography. For these experiments a larger quan-
tity of cells was used and the MBcAMP fraction
resulting from metabolism of DBcAMP was iso-
lated as usual. The absorption maximum of the
fraction after elution was determined between
250 and 280 nM, and the relative quantity of
the two derivatives was calculated . N6-MBcAMP
exhibits an absorption maximum at 272 nM
and O2'-MBcAMP at 258 nM and, since the ex-
tinction coefficients of both compounds are simi-
lar, it is possible to estimate, approximately,
the percentage of each present by determining
the absorption maximum of the mixture (i.e.,
(272-Xmax)/(272-258) X 100 = percent 02'-
MBcAMP) (33) . Estimates of the amounts of Ns-
and 02'-MBcAMP using this method were simi-
lar to those made with the alkali treatment pro-
cedure.
Estimates of the intracellular concentration of
DBcAMP and its metabolites can be made if the
cellular volume is known. Several experiments
were conducted in an effort to measure cellular
volumes, and the results varied to some extent
as a function of the harvesting procedure, the
age of the cells, and so forth . In any event, values
between 4 and 6.5 X 10-12 liters per cell for
each of the lines were obtained in the different
experiments.
Using these estimated cellular volumes, the
intracellular concentration of DBcAMP can be
calculated to be approximately 0.3 mM in all
four cell lines. The calculated intracellular con-
centrations of the presumptively active com-
pounds, N6-MBcAMP and cAMP (32), were
roughly 0.05 mM and 0.03 mM, respectively,
with the exception of MH ICI cells where ap-
proximately 50% more DBcAMP was converted
to these metabolites (see Table V) .
DISCUSSION
The responses observed in the present experi-
ments suggest that MH1C1 cells have retained the
same regulatory mechanisms, with respect to
those examined, as H35 cells, with one exception ;
the regulation of tyrosine transaminase by cAMP
analogs. In contrast, the HTC and RLC cells
both appear to have lost (or never possessed)
key components in most of these regulatory
processes. Although a weak elevation of trans-
aminase activity can be achieved with DBcAMP
in HTC cells, as Stellwagen has also reported
(34), no other responses to cAMP analogs were
observed in these cells and no responses at all
were found with RLC cells.
The trivial possibility that these cells are re-
sistant to DBcAMP because of reduced uptake
of impaired conversion to Ns-MBcAMP4 or
cAMP would appear unlikely on the basis of
the present results (see Table V) . Furthermore,
employment of 8-substituted analogs of cAMP
which are active as enzyme inducers in H35 and
MH1CI cells (19, 20) did not produce any sig-
nificant responses in HTC or RLC cells above
and beyond those seen with DBcAMP. The 8-
substituted analogs contain no butyric acid and
are capable of activating protein kinase in vitro
as well as inhibiting phosphodiesterase activity
(30, 35). The defect in HTC and RLC cells
would, therefore, appear to be in the intracellular
response of these cells to cAMP (or N 6-MBcAMP,
etc.) .
One obvious candidate for the key lesion is the
cAMP-dependent protein kinase (36). There
are no data, to our knowledge, with reference
to this possibility in RLC cells but Granner has
reported that both subunits of this enzyme (36)
are present in HTC cells (37) . Although there
appears to be a diminished amount of the cAMP-
binding subunit (and hence a reduced depend-
ency on cAMP), it is possible to obtain stimula-
tion of histone phosphorylation with HTC cell
extracts in vitro (37). If the Km of the regulatory
subunit for cAMP (or NI-MBcAMP) was altered,
this could conceivably account for the require-
ment for higher concentrations of DBcAMP to
4 We have tested N6-MBcAMP as an enzyme in-
ducer and it is about as effective as DBcAMP in
H35 cells, but has no effect in HTC cells . 02r-
MBcAMP, in contrast, is inactive as an inducer.
These results are consistent with N6-MBcAMP being
an active intracellular inducer . Dr. Jon Miller at
the ICN Nucleic Acid Research Institute has ob-
tained identical results in studies of these analogs
as inducers of the transaminase in adrenalectomized
rats (personal communication) . He has also found
that among these three, only N6-MBcAMP is an
effective activator of rat liver protein kinase and
only DBcAMP and N6-MBcAMP are resistant to
hydrolysis by phosphodiesterase . These results thus
provide a logical explanation both for the lack of
effect of 02'-MBcAMP and the activity of DBcAMP
and N6-MBcAMP in H35 cells .
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nase activity, but not for the lack of effect of
cAMP analogs on PEP carboxykinase activity
or DNA synthesis.
H35 cells possess a cAMP-dependent protein
kinase as judged by in vitro assays' and by the
fact that f1 histone phosphorylation can be stimu-
lated in intact H35 cells by DBcAMP .' MH1C1
cells also contain a protein kinase which is the
same as in H35 cells both in terms of basal activ-
ity and cAMP stimulability.' Examination of
RLC cells for protein kinase activity will be
conducted shortly. It should be stressed at this
point that there is no direct evidence that the
effects of cAMP on either enzyme induction or
growth regulation are mediated by a cAMP-
dependent protein kinase. However, there is at
present no well-defined alternative mechanism
by which cAMP has been shown to act in eu-
karyotic cells and, therefore, it seems only reason-
able to suggest that protein kinase is involved .
Indirect support for this suggestion is provided
by the fact that there is a correlation between the
ability of various analogs of cAMP to induce
tyrosine transaminase and to activate rat liver
protein kinase in vitro (7, 19, 20, 35) . In addi-
tion, only cAMP analogs that are enzyme indu-
cers are capable of regulating the growth of
H35 and MHICI cells (19, 20).'
It is possible that the low activity of the car-
boxykinase in HTC and RLC cells is due to the
fact that only the mitochondrial isozyme is
present. The isozyme in the cytosol is subject to
hormonal or dietary regulation in rat liver, but
that in the mitochondrion is resistant to such
regulation (38-40) . Unfortunately, it is essen-
tially impossible to distinguish between the cyto-
solic and mitochondrial isozymes by differences
in nucleotide or metal ion specificities or on
kinetic grounds (40, 41) . The activity of the
carboxykinase in these cells is also so low that,
although theoretically possible (40), immuno-
logical differentiation would be technically
difficult.
There are at least two other possible explana-
tions for the variable responses to DBcAMP seen
in the HTC, RLC, and MH1C1 cells. The first is
that there are different protein kinases for each
physiological response subject to regulation by
cAMP and that one or more of these has been
altered or lost during oncogenesis or continuous
' W. D. Wicks. Unpublished observations.
s T. A. Langan. Personal communication.
188
	
THE JOURNAL OF CELL BIOLOGY . VOLUME 00, 1974
growth in culture. Thus, if three different pro-
tein kinases mediated the effects of DBcAMP on
the transaminase, carboxykinase, and DNA syn-
thesis, then the loss of or marked reduction in
the first of these with the MH1C1 cells, a marked
alteration in the first and loss of the second and
third of these in HTC cells, and the loss of all
three in the RLC cells could also explain the ob-
served responses. (The "loss" of cAMP-dependent
protein kinase would presumably relate to loss
of or major reduction in the content of either the
regulatory cAMP-binding or catalytic subunit
[37].) Although the results in HTC cells are con-
sistent with this possibility to some extent (34,
37), this does not seem very likely to be a major
factor for several reasons . Although two, and pos-
sibly three, isozymes of protein kinase have been
reported in rat liver, there is no significant dif-
ference in either the affinity for cAMP or in the
protein substrate specificity among the isozymes
(42, 43). Furthermore, there are clearly more
than two to three discrete responses affected by
cAMP in liver (6, 44-48) . Finally, the same
protein kinase appears to catalyze the phospho-
rylation of phosphorylase b kinase and glycogen
synthetase I in skeletal muscle (36).
A more likely possibility would appear to be
the deletion of or alteration in key protein sub-
strates for the cAMP-dependent kinase . This
would eliminate the arguments discussed above
and could completely account for the differential
responses observed. The fact that tyrosine trans-
aminase is present and still responds to glucocor-
ticoids in HTC and RLC cells also suggests that
the defect in the regulation of the synthesis of
this enzyme is relatively subtle. The fact that
certain liver ribosomal proteins are subject to
cAMP-dependent phosphorylation (49-50) and
the evidence which strongly indicates that cAMP
acts at the translational level in regulating the
synthesis of tyrosine transaminase and PEP
carboxykinase (39, 51-53) argue for a functional
relationship between these events . It is not pos-
sible as yet, however, to do more than speculate
about this relationship, as has been done with
fI histone phosphorylation and enzyme induction
(48) . It is clear that if the differential responses
observed in these studies result at least in part
from protein substrate alterations, that attempts
to determine whether ribosomal protein phos-
phorylation is in fact associated with enzyme
induction in a cause-effect relationship would be
greatly facilitated.The fact that DBcAMP has very little effect
on transaminase activity in MH,C, cells in spite
of the fact that the carboxykinase responds nor-
mally and both enzymes are elevated by dexa-
methasone provides additional convincing evi-
dence that CAMP does not mediate the effects
of glucocorticoids on enzyme induction (6, 27,
28, 39).
The pattern of response of PEP carboxykinase
to dexamethasone in H35, MH1C1, HTC, and
RLC cells is analogous to that reported for
phenylalanine hydroxylase by Haggerty et al.
(54).These results underscore the basic similarity of
H35 and MH1C1 cells in terms of the regulatory
processes studied to date. It will be of interest to
see if phenylalanine hydroxylase can be induced
in MH1C1 cells by DBcAMP as is the case in
H35 cells (54) .
The mechanism by which DBcAMP inhibits
the growth rate of MHICI cells appears to be
analogous to that in H35 cells . The kinetics of
inhibition of DNA synthesis and growth rate are
similar in both cell lines and deoxycytidine re-
verses the effects of the sAMP analog in each
(19, 20, 25).
Although detailed studies localizing the site
of action of DBcAMP in the cell cycle of MHICI
cells have not yet been performed, the present
results are consistent with a prolongation of the
DNA replicative phase of the cell cycle of these
cells as in the case with H35 cells (19, 25) . This
effect would appear to account for both the in-
hibition of growth and increase in protein con-
tent in MH1C1 and H35 cells. Since cells take a
longer time to traverse the cell cycle in the pres-
ence of DBcAMP, a proportionately greater
amount of protein is synthesized per cell (20).
The degree of increase in protein content in
both cell lines correlates roughly with the in-
crease in generation time.
The fact that the intracellular concentration
of DBcAMP 30-60 min after its addition is only
slightly less than that in the medium suggests
that the various cells are probably freely per-
meable to the cyclic nucleotide . The concentra-
tion of Ns-MBcAMP can be estimated to be
about 0.05 mM in all but the MH1C, cells where
it is about 0.08 mM. The cAMP concentration
is roughly 0.03 mM in all but the MH ICI cells
where it is proportionately higher. The concen-
trations of N6-MBcAMP and sAMP are not far
above those of free sAMP achieved in rat liver
after exposure to glucagon (45, 47) . Although
these are only crude estimates of the intracellular
concentration of DBcAMP, NI-MBcAMP, and
CAMP, they suggest that the intracellular re-
sponsiveness of H35 and MHICI cells is similar
to that of normal rat liver . Indeed, minimal
effects of DBcAMP on both enzyme induction
and growth rate can be obtained with exogenous
concentrations as low as 10-20 µM (6, 19), which
is well within the range of hormonally induced
fluctuations in hepatic sAMP concentrations
(45, 47) and, in view of the present results, the
intracellular concentration of active metabolites
of DBcAMP (i.e., presumably N6-MBcAMP and
sAMP) would be expected to be even less than
that of DBcAMP in the medium.
Although the present hepatoma cell lines con-
stitute only a modest set of variants, comparative
analysis of their responses to DBcAMP suggests
that they may well provide starting material for
the isolation of a large number of variants which
could be of great assistance in the elucidation of
the mechanism by which cAMP regulates specific
protein synthesis and growth rate .
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